Lai Wang sold $296k of ONC
President, Global Head of R&D at BeOne Medicines Ltd.. 1,068 shares at an average of $276.74, traded Jun 23, 2026, filed Jun 25, 2026.
Score components
- +20RolePresident
- +14Trade size$296k at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster6 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001852291-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | SOpen-market sale American Depositary Shares | -1,068 | $276.74 | $296k | 0 | Jun 25, 2026 |
Related signals
Other insiders at BeOne Medicines Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeOne Medicines Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 40Moderate | BeOne Medicines Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 56Moderate | BeOne Medicines Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 45Moderate | BeOne Medicines Ltd. | Xiaobin Wu President and COO | $106k 280 shares | -100% | |
| 39Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $960k 2,666 shares | -100% | |
| 65Notable | BeOne Medicines Ltd. | John Oyler Chief Executive Officer | $86M 240,810 shares | -100% | |
| 72Notable | BeOne Medicines Ltd. | Aaron Rosenberg Chief Financial Officer | $362k 1,157 shares | -100% | |
| 65Notable | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $338k 1,044 shares | -100% | |
| 34Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $542k 1,669 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.